Amino-terminal proCNP: A putative marker of cartilage activity in postnatal growth

Pediatric Research

Volumn 58, Issue 2, 2005, Pages 334-340

  Prickett, Timothy C R ^a   Lynn, Adrienne M ^b   Barrell, Graham K ^c   Darlow, Brian A ^b   Cameron, Vicky A ^a   Espiner, Eric A ^a   Richards, A Mark ^a   Yandle, Timothy G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c LINCOLN UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL PRO NATRIURETIC PEPTIDE TYPE C; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEXAMETHASONE; GLUCOCORTICOID; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BONE GROWTH; BONE TURNOVER; CARTILAGE; CHILD; CONTROLLED STUDY; DRUG EFFECT; ENCHONDRAL OSSIFICATION; FEMALE; GROWTH PLATE; GROWTH RATE; HUMAN; LAMB; MALE; METACARPAL BONE; NEWBORN; NONHUMAN; NORMAL HUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; RODENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; BONE DEVELOPMENT; CARTILAGE; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CHONDROCYTES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXAMETHASONE; FETAL BLOOD; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; OSTEOGENESIS; PEPTIDES; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; SHEEP; TIME FACTORS;

EID: 23244466225     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000169964.66260.4B     Document Type: Article

References (44)

1. Kronenberg HM 2003 Developmental regulation of the growth plate. Nature 423:332-336
2. Espiner EA, Richards AM, Yandle TG, Nicholls MG 1995 Natriuretic hormones. Endocrinol Metab Clin North Am 24:481-509
3. Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG 1994 Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 78:1428-1435
4. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV 1991 Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252:120-123
5. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H 1991 C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun 177:927-931
6. Yamahara K, Itoh H, Chun TH, Ogawa Y, Yamashita J, Sawada N, Fukunaga Y, Sone M, Yurugi-Kobayashi T, Miyashita K, Tsujimoto H, Kook H, Feil R, Garbers DL, Hofmann F, Nakao K 2003 Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci USA 100:3404-3409
7. Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S, Hirose S 1994 Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem 269:10729-10733
8. Yasoda A, Ogawa Y, Suda M, Tamura N, Mori K, Sakuma Y, Chusho H, Shiota K, Tanaka K, Nakao K 1998 Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem 273:11695-11700
9. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K 2001 Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 98:4016-4021
10. Bartels CF, Bukulmez H, Padayatti P, Rhee DK, van Ravenswaaij-Art C, Pauli RM, Mundlos S, Chitayat D, Shih L, Al-Gazali LI, Kant S, Cole T, Morton J, Cormier-Daire V, Faivre L, Lees M, Kirk J, Mortier GR, Leroy J, Zabel B, Kim CA, Crow Y, Braverman NE, van der Akker F, Warman ML 2004 Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75:27-34
11. Sundsfjord JA, Thibault G, Larochelle P, Cantin M 1988 Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 66:605-610
12. Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA 1995 The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 214:1175-1183
13. Prickett TC, Yandle TG, Nicholls MG, Espiner EA, Richards AM 2001 Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun 286:513-517
14. Yandle TG, Fisher S, Charles C, Espiner EA, Richards AM 1993 The ovine hypothalamus and pituitary have markedly different distributions of C-type natriuretic peptide forms. Peptides 14:713-716
15. Komatsu Y, Chusho H, Tamura N, Yasoda A, Miyazawa T, Suda M, Miura M, Ogawa Y, Nakao K 2002 Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice. J Bone Miner Metab 20:331-336
16. Wright SP, Prickett TC, Doughty RN, Frampton C, Gamble GD, Yandle TG, Sharpe N, Richards M 2004 Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension 43:94-100
17. Wu C, Wu F, Pan J, Morser J, Wu Q 2003 Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem 278:25847-25852
18. Yandle TG 1994 Biochemistry of natriuretic peptides. J Intern Med 235:561-576
19. Yamashita Y, Takeshige K, Inoue A, Hirose S, Takamori A, Hagiwara H 2000 Concentration of mRNA for the natriuretic peptide receptor-C in hypertrophic chondrocytes of the fetal mouse tibia. J Biochem (Tokyo) 127:177-179
20. Sales N, Dutriez I, Maziere B, Ottaviani M, Roques BP 1991 Neutral endopeptidase 24.11 in rat peripheral tissues: comparative localization by 'ex vivo' and 'in vitro' autoradiography. Regul Pept 33:209-222
21. Kojima M, Minamino N, Kangawa K, Matsuo H 1990 Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett 276:209-213
22. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H 1992 Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system." J Clin Invest 90:1145-1149
23. Minamino N, Aburaya M, Kojima M, Miyamoto K, Kangawa K, Matsuo H 1993 Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue. Biochem Biophys Res Commun 197:326-335
24. Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA 1996 The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 137:817-824
25. Prickett TC, Kaaja RJ, Nicholls MG, Espiner EA, Richards AM, Yandle TG 2004 N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation. Clin Sci (Lond) 106:535-540
26. Deloof S, Van Camp G, Chatelain A 1995 Absence of transplacental transfer of atrial natriuretic peptide in the rat: direct experimental evidence. Med Sci Res 23:347-349
27. Byers S, Moore AJ, Byard RW, Fazzalari NL 2000 Quantitative histomorphometric analysis of the human growth plate from birth to adolescence. Bone 27:495-501
28. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS 2002 Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90:254-258
29. Seibold-Weiger K, Wollmann HA, Ranke MB, Speer CP 2000 Plasma concentrations of the carboxyterminal propeptide of type I procollagen (PICP) in preterm neonates from birth to term. Pediatr Res 48:104-108
30. Kajantie E, Hytinantti T, Koistinen R, Risteli J, Rutanen EM, Seppala M, Andersson S 2001 Markers of type 1 and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment. Pediatr Res 49:481-489
31. Javaid MK, Godfrey KM, Taylor P, Shore SR, Breier B, Arden NK, Cooper C 2004 Umbilical venous IGF-1 concentration, neonatal bone mass, and body composition. J Bone Miner Res 19:56-63
32. Javaid MK, Taylor P, Shore SR, Gale C, Callagham FO, Godfrey KM, Cooper C 2003 Umbilical vein calcium concentration and maternal vitamin D status predict the mass of children at age nine years. Osteoporos Int 14(Suppl 1):S13
33. Siebler T, Robson H, Shalet SM, Williams GR 2002 Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells. Bone 31:457-464
34. Ballock RT, O'Keefe RJ 2003 The biology of the growth plate. J Bone Joint Surg 85:715-726
35. Mushtaq T, Bijman P, Ahmed SF, Farquharson C 2004 Insulin-like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid-mediated growth retardation in fetal mice metatarsal cultures. Endocrinology 145:2478-2486
36. Tawaragi Y, Fuchimura K, Tanaka S, Minamino N, Kangawa K, Matsuo H 1991 Gene and precursor structures of human C-type natriuretic peptide. Biochem Biophys Res Commun 175:645-651
37. Miyazaki Y, Tsukazaki T, Hirota Y, Yonekura A, Osaki M, Shindo H, Yamashita S 2000 Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes. Osteoarthritis Cartilage 8:378-385
38. Ohta S, Shimekake Y, Nagata K 1996 Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur J Biochem 242:460-466
39. Danielpour D, Kim KY, Winokur TS, Sporn MB 1991 Differential regulation of the expression of transforming growth factor-beta s 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J Cell Physiol 148:235-244
40. Potchinsky M, Nugent P, Lafferty C, Greene RM 1996 Effects of dexamethasone on the expression of transforming growth factor-beta in mouse embryonic palatal mesenchymal cells. J Cell Physiol 166:380-386
41. Chikuda H, Kugimiya F, Hoshi K, Ikeda T, Ogasawara T, Shimoaka T, Kawano H, Kamekura S, Tsuchida A, Yokoi N, Nakamura K, Komeda K, Chung UI, Kawaguchi H 2004 Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev 18:2418-2429
42. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K 2004 Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10:80-86
43. Komatsu Y, Itoh H, Suga S, Igaki T, Ogawa Y, Kishimoto I, Nakagawa O, Yoshimasa T, Nakao K 1996 Regulation of secretion and clearance of C-type natriuretic peptide in the interaction of vascular endothelial cells and smooth muscle cells. J Hypertens 14:585-592
44. Robson H, Anderson E, Eden OB, Isaksson O, Shalet S 1998 Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation. J Endocrinol 157:225-235